NCT06678256View on ClinicalTrials.gov

A Study of Pregnancy Outcomes in Congenital Heart Disease

SuspendedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2026

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions
Congenital Heart Disease
Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Mayo Clinic

OTHER

NCT06678256 - A Study of Pregnancy Outcomes in Congenital Heart Disease | Biotech Hunter | Biotech Hunter